Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting tumor associated macrophages (TAMs) via nanocarriers.

Journal of controlled release : official journal of the Controlled Release Society - 28 May 2017

Singh Yuvraj, Pawar Vivek Kumar, Meher Jaya Gopal, Raval Kavit, Kumar Animesh, Shrivastava Richa, Bhadauria Smrati, Chourasia Manish K

Abstract excerpt

Recruitment of inflammatory cells to tumor has been well documented, with the most frequent inhabitants being macrophages termed as tumor associated macrophages, (TAMs). Their presence was thought to be an evidence of immune system initiating a fight response towards the tumor, i.e. immune surveillance. This is the case too initially, when TAMs majorly exhibit an M1 phenotype, but their continued presence in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Drug Carriers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Nanostructures

Share to Neoplasm Invasiveness

Share to Neoplasm Metastasis

Share to Tumor Microenvironment

Source

Identifiers

PMID: 28377038
DOI: 10.1016/j.jconrel.2017.03.395

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting tumor associated macrophages (TAMs) via nanocarriers.PMID 28377038Read ↗

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.Semantic proximity Read ↗

How to use macrophages to realise the treatment of tumour.Semantic proximity Read ↗

Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages.Semantic proximity Read ↗

Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting.Semantic proximity Read ↗

Tumor-associated macrophages: functional diversity, clinical significance, and open questions.Semantic proximity Read ↗

A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes.Semantic proximity Read ↗

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.Semantic proximity Read ↗

Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach.Semantic proximity Read ↗

TAMeless traitors: macrophages in cancer progression and metastasisSemantic proximity Read ↗

[Influencing Factors and Significance of Tumor-associated Macrophage Polarization in Tumor Microenvironment].Semantic proximity Read ↗

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.Semantic proximity Read ↗

Tissue‐Resident Macrophages in Cancer: Friend or Foe?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.